Drug retail terminal needs to break through (Figure)

August 14, 11 strong typhoon YUTE from the eastern coast of Hainan landing Unexpectedly, Utah, whose wind power once reached 15, turned away gently in the northeast of Hainan Island, and the "information conference of China's drug retail industry" attended by nearly 2000 people was held in Boao as scheduled As a drug retail industry greatly affected by the policy, it also did not usher in the storm, but it is not a sunny day In the context of the slowdown of national economic growth, China's pharmaceutical retail industry is also trying to adapt to the impact of the new medical reform, and in the adverse factors of rising costs and falling profits, looking for opportunities, looking forward to breakthroughs, and persistently exploring the driving force of industrial development Ushering in the era of "weak growth", according to the blue book on analysis of six terminal drug markets in China's pharmaceutical industry (2012-2013) released by Zhongkang information, in 2012, the total scale of China's drug terminal market reached 975.5 billion yuan, an increase of 18.1% year-on-year; it is expected that the total amount in 2013 will reach 1145.8 billion yuan, breaking through the trillion yuan mark, an increase of 17.5% year-on-year "In recent years, China's drug terminal market has maintained a relatively stable growth." Wu Shu, general manager of Zhongkang information, said that through the rapid development in the past few years, the growth rate of drug retail industry has slowed down in recent years, entering the era of weak growth, and gradually showing signs of insufficient aftereffect: the industry is trapped in the tangle of cost and profit, the reconstruction of channels and terminals; the confusion of direction choice facing drugstores, the test of consumer stickiness; the growth curve of industrial scale and profit It shows the characteristics of shock sorting, which leads to the collective "anxiety" of practitioners, eager to seek new fulcrum of growth For a long time, some people in the industry have divided the pharmaceutical market into the so-called hospital, drugstore and grass-roots terminal markets In recent years, with the promotion of the new medical reform, Zhongkang information redefines the drug market, which is subdivided into six terminals: city level hospital market, county level hospital market, city basic level medical market, rural basic level medical market, entity retail drugstore market and online drugstore market According to Wu Han, further segmentation of the terminal market will help the industry more accurately understand the drug use characteristics and growth laws of different terminals According to the data, in 2012, the market scale of city level hospitals (second and third level hospitals in prefecture level and above cities, including military hospitals) reached 531.4 billion yuan, an increase of 18.5% year on year, and it is expected to increase by 17.8% in 2013 "This market is still the largest and fastest growing medical terminal in the future, but its growth rate has slowed down due to factors such as medical insurance control fees." He pointed out that "in 2012, the county level hospital market (county level II and above hospitals, including military hospitals) reached 156 billion yuan, an increase of 26% With the increase of financial investment in county-level hospitals by the new medical reform, the market will continue to grow rapidly in the next few years, and the market share will continue to expand " However, the performance of retail drugstore market is not satisfactory, and the growth is relatively low The above data also shows that the retail terminal market in 2012 was 230.9 billion yuan, an increase of 13% compared with 2011 Among them, drug sales reached 179.9 billion yuan, a year-on-year increase of 16%; non drug sales reached 51 billion yuan, a year-on-year increase of 4% It is estimated that the market scale will reach 256.6 billion yuan in 2013, with a growth rate of 11% In terms of the number of drugstores, in 2012, the total number of Chinese drugstores reached 435969, an increase of 2% compared with 2011 However, there are 180000 chain stores, only 41% of which are chain drugstores, of which 35% are franchise stores, and only 27% are direct stores Low concentration and low chain rate are still the biggest obstacles to the development of drugstores "At present, the development of retail pharmacies is facing new situations and challenges." Wen Zaixing, inspector of the market order Department of the Ministry of Commerce, stressed that at present, the development of retail pharmacies is slow According to the authoritative statistics of the Ministry of Commerce, the sales volume of the top 100 drug retail enterprises accounted for 34.3% of the total sales volume of the market in 2012, and the chain rate of retail pharmacies was 34.6%, down 0.76 percentage points compared with 2008 Compared with the goal of "two thirds chain" proposed in the 12th Five year development plan outline, the retail pharmacies are still developing slowly Large gap; the development of retail chain drugstores is still facing many obstacles, and the diversified operation is hindered In some big cities, the cost rate of drugstores is too high, the survival and development of drugstores are facing difficulties, and some drugstores have closed down; the implementation of the newly revised Drug GSP is also a severe test for retail drugstores At the same time, with the further development of the new medical reform, especially the popularization of basic medical institutions, the inclination of medical institutions such as medical insurance system, etc., the drugstore passenger flow continues to decline "In recent years, retail pharmacies have tried to" diversify "operation in order to get rid of difficulties The implementation of non drug sales restriction in medical insurance stores nationwide has greatly reduced the diversification, while the advantages of health care products, medical devices, food, daily chemicals and other commodities in pharmacies are not obvious." One participant told reporters According to the data of Zhongkang information, the mainstream cosmetics brands such as Weizi, rifuquan and yayang have gradually faded out of the drugstore market, and the sales of cosmetics in drugstores have declined sharply, with a year-on-year decrease of 33% At the same time, the two major non drug markets of health products and medical devices are also close to saturation, with a significant slowdown in growth Only food is growing rapidly, but its scale is small and its driving force is limited "The reform of drug retail industry should be accelerated The general requirements of the State Council for drug production and circulation are eight words: safe, effective, convenient and timely." Convenient and timely realization depends on modern circulation, especially more than 400000 drug retail stores in urban and rural areas The most important responsibility of drug retail stores is to facilitate the masses " When it comes to drug retail industry, Yu Mingde, President of China Pharmaceutical Enterprise Management Association, said In recent years, it has become a consensus that the era of great health has become a new opportunity for industry development However, from the feedback of business status, the opportunities brought by big health did not bring enough support to the development of the industry, on the contrary, the performance of non drugs was relatively weak and weak, even slightly declined in 2012 Mining and developing the potential demand of consumers is also expected to become a new growth power The good news is that infant formula will be tried out in the drugstore "At present, the market scale of infant milk powder reaches 38.5 billion yuan, which will effectively promote the diversified operation of pharmacies." Mr Wu said However, some experts also pointed out that in terms of the exploration and satisfaction of consumers' health needs, both sides of industry and commerce still have more than enough efforts It is an urgent task to seek new impetus for the development of the industry The transformation and development of drug distribution industry is imminent, and relevant departments have begun to pay close attention to the transformation of drug retail industry According to Wen Zaixing, while promoting the transformation of wholesale enterprises from traditional drug suppliers to comprehensive service providers of pharmaceutical logistics, the Ministry of commerce also actively promotes and encourages qualified pharmaceutical retail enterprises to diversify their development "At present, various hospital store cooperation is being carried out around the country to undertake the exploration of new models such as hospital pharmacy In 2012, we held the hospital pharmacy cooperation in Yunnan On site meeting In addition, we also encourage retail pharmacies to actively carry out diversified operation and provide health management services for the people " He said that more than 400000 retail pharmacies across the country are close to the community and are important channels and commercial resources The Ministry of Commerce encourages retail pharmacies to speed up diversified operation, promote the consumption of brand health products, meet the diversified needs of consumers for health and a better life, and gradually build retail pharmacies into a platform of great health, so that the majority of people form the habit of "looking for pharmacies" "In addition, the 12th Five year plan proposes to encourage the healthy development of retail pharmacies, allow traditional Chinese medicine to sit in pharmacies, and actively explore and carry out other diversified services for health management." With the rapid development of IT technology, the Internet also promotes the transformation of retail formats in the pharmaceutical market According to the data of Zhongkang information, in 2012, the sales scale of online pharmacies in China reached 1.7 billion yuan, four times more than that in 2011, and the transaction scale is expected to reach 4 billion yuan in 2013 It is understood that in 2012, China's pharmaceutical B2C transaction scale began to show explosive growth, and with the increase of the number of pharmaceutical B2C enterprises, further promote the development of the pharmaceutical retail online shopping market Wen Zaixing said that the total number of Internet users in China is 510 million, and they are more inclined to choose cheap and diversified options Retail pharmacies should be prepared for safety, pay attention to the rise of online shopping, make early plans, at least make adjustments in product brands and differentiated management In a word, the pharmaceutical retail industry is facing great changes What is the way out for retail pharmacies? It needs serious consideration of the industry "Commercial circulation is the blood of economic operation China's economy is changing from production oriented to consumption oriented We hope that industrial and commercial enterprises will further increase cooperation and jointly explore new ways and models for the transformation and development of drug circulation industry, especially for the characteristics of retail pharmacies, to develop and produce more high-quality health products and provide better health services for urban and rural people I believe that joint efforts and common development will surely promote the healthy and sustainable development of the drug distribution industry " Wen Zaixing stressed Relevant links: the first eight chain drugstores of Jingdong pharmaceutical city were launched at the end of August Recently, Jingdong Mall announced that Jingdong pharmaceutical city will be officially launched at the end of August The first eight regional drugstores have reached cooperation with Jingdong pharmaceutical city The eight chain drugstores will be the exclusive cooperative merchants in Jingdong pharmaceutical City, including Jingwei pharmacy in Beijing, Fumei pharmacy in Shanghai, Shuyu civilian pharmacy in Jinan, Shandong, Zoomlion pharmacy in Wuhan, Hubei, Huatuo pharmacy in Zhangjiakou, Hebei, ertiantang pharmacy in Guangzhou, Guangdong, deshengtang pharmacy in Lanzhou, Gansu, Huairen pharmacy in Huaihua, Hunan Room According to the person in charge of Jingdong pharmaceutical City, Jingdong pharmaceutical city itself is positioned as a pharmaceutical e-commerce service provider By introducing chain drugstores with internet pharmaceutical trading license qualification in the main channel of pharmaceutical retail as merchants, it is committed to becoming an open platform specialized in providing regional health product retail and pharmaceutical services The above people pointed out that the pharmaceutical city itself does not sell products, and the sales and service functions are carried out by the settled businesses In the future, it is hoped that under the support and supervision of the regulatory authorities, it will further build into an online physician consultation platform, gradually form a health management platform starting from major disease management, and become a professional health consultant around users According to people familiar with the matter, the merchants in Jingdong pharmaceutical city must be local large chain drugstores with Internet drug information service qualification certificate and Internet drug transaction service qualification certificate, with independent commodity release, back office management, payment system and other systems Moreover, Jingdong pharmaceutical City selects merchants from provinces and cities, and only customers in corresponding regions To purchase the goods in this store.